AllianceBernstein’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-38,230
| Closed | -$573K | – | 3017 |
|
|
2016
Q2 | $573K | Buy |
38,230
+8,600
| +29% | +$110K | ﹤0.01% | 2469 |
|
|
2016
Q1 | $361K | Sell |
29,630
-3,600
| -11% | -$50.5K | ﹤0.01% | 2523 |
|
|
2015
Q4 | $529K | Sell |
33,230
-2,600
| -7% | -$40.9K | ﹤0.01% | 2435 |
|
|
2015
Q3 | $549K | Sell |
35,830
-70
| -0.2% | -$1.51K | ﹤0.01% | 2455 |
|
|
2015
Q2 | $873K | Buy |
35,900
+3,600
| +11% | +$86.2K | ﹤0.01% | 2349 |
|
|
2015
Q1 | $751K | Sell |
32,300
-2,500
| -7% | -$66.2K | ﹤0.01% | 2330 |
|
|
2014
Q4 | $874K | Hold |
34,800
| – | – | ﹤0.01% | 2282 |
|
|
2014
Q3 | $1.08M | Buy |
34,800
+3,800
| +12% | +$103K | ﹤0.01% | 2147 |
|
|
2014
Q2 | $802K | Buy |
31,000
+5,100
| +20% | +$113K | ﹤0.01% | 2360 |
|
|
2014
Q1 | $605K | Sell |
25,900
-2,500
| -9% | -$54.7K | ﹤0.01% | 2368 |
|
|
2013
Q4 | $721K | Buy |
28,400
+5,943
| +26% | +$134K | ﹤0.01% | 2304 |
|
|
2013
Q3 | $458K | Sell |
22,457
-1,115
| -5% | -$24.8K | ﹤0.01% | 2517 |
|
|
2013
Q2 | $495K | Buy |
+23,572
| New | +$421K | ﹤0.01% | 2497 |
|
AllianceBernstein's SGNT Position: Q3 2016 in Review
AllianceBernstein sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 38,230 shares — an estimated $573K sold.
AllianceBernstein first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $1.08M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.
- AllianceBernstein reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
- AllianceBernstein sold 38,230 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $573K.
- AllianceBernstein first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
- AllianceBernstein's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.08M in Q3 2014.
- 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.